Athanassiades T J
Infect Immun. 1977 Nov;18(2):416-23. doi: 10.1128/iai.18.2.416-423.1977.
The subcutaneous route (s.c.) was used to study the adjuvant effect of Bordetella pertussis vaccine (PV) on cell-mediated immunity to sheep erythorcytes (SRBC). The immune response was measured by a sensitive assay procedure in which the antigen is injected intracutaneously into the mouse ear and the inflammatory swelling is measured with calipers. PV significantly enhanced cell-mediated immunity to SRBC, and the enhancement persisted for at least 3 weeks. PV administered up to 6 days before SRBC also significantly enhanced the response; PV injected 1 or more days after SRBC was not effective. In addition, it was found that PV per se released into the suspension medium a cell-free component(s) (pertussis supernatant) that contributed significantly to adjuvanticity. The adjuvanticity of both PV and PS was completely eliminated by heat.
采用皮下注射途径(s.c.)研究百日咳博德特氏菌疫苗(PV)对针对绵羊红细胞(SRBC)的细胞介导免疫的佐剂效应。通过一种灵敏的检测程序来测定免疫反应,该程序是将抗原皮内注射到小鼠耳部,并用卡尺测量炎性肿胀。PV显著增强了针对SRBC的细胞介导免疫,且这种增强作用持续至少3周。在注射SRBC前6天内给予PV也能显著增强反应;在注射SRBC后1天或更长时间注射PV则无效。此外,发现PV本身会向悬浮培养基中释放一种无细胞成分(百日咳上清液),该成分对佐剂性有显著贡献。PV和PS的佐剂性均通过加热被完全消除。